Ubs Group Ag Tela Bio, Inc. Put Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TELA
# of Institutions
50Shares Held
23.8MCall Options Held
764KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT5.11MShares$7.72 Million0.43% of portfolio
-
Essex Woodlands Management, Inc. The Woodlands, TX4.11MShares$6.21 Million2.86% of portfolio
-
Silverarc Capital Management, LLC2.78MShares$4.2 Million1.3% of portfolio
-
Stonepine Capital Management, LLC Bend, OR2.08MShares$3.15 Million3.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.91MShares$2.89 Million0.0% of portfolio
About TELA Bio, Inc.
- Ticker TELA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 19,157,600
- Market Cap $28.9M
- Description
- TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...